Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Gefitinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 3 Respiratory Tract Diseases 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 EGFR-mutant Non-small Cell Lung Cancer 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7 Specimen Handling 6 Biopsy 6 X-Rays 4 Phantoms, Imaging 4 Nuclear Medicine Department, Hospital 4 selpercatinib 3 larotrectinib 3 Nivolumab 3 Cyclophosphamide 3 Carboplatin 3 Automobiles 3 pembrolizumab 2 fludarabine 2 erdafitinib 2 entrectinib 2 ensartinib 2 Temozolomide 2 Surveys and Questionnaires 2 Radiotherapy 2 Radiosurgery 2 Positron-Emission Tomography 2 ONC206 2 Magnetic Resonance Imaging 2 Lomustine 2 Ipilimumab 2 Etoposide 2 Cisplatin 2 ulixertinib 1 tozuleristide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡